Contact Us
Request Access
  1. Home
  2. News – Rx-360 Alerts

News – Rx-360 Alerts

FDA Says Up to Two Million People Exposed to Likely Carcinogens in Blood-Pressure Drugs
Revisoin 7 of ICH Q3C Guideline for Residual Solvents
Five additional countries to benefit from EU-US mutual recognition agreement for inspections | European Medicines…
Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality…
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable…
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide
5 Strategies To Combat Counterfeit Drugs And Other Pharma Supply Chain Threats
Mylan and Pfizer Report New Issues Affecting Some EpiPens That Can Delay Treatment
FDA Gains New Powers to Block Illicit Drug Imports
FDA Updates on Valsartan Recalls
FDA Updates on Valsartan Recalls
The Uphill Fight Against Fake Prescription Drugs
MHRA Says Falsified Medicines Directive Could Cost £500m Over Ten Years